For the second year running, Ameliot will co-host an international conference on medical technology design in trauma surgery in collaboration with the Justus Liebig University of Giessen, funded by the DFG German Research Foundation. This conference will take place between 11-13 October 2019 in Giessen, Germany.

The 2019 conference will bring together a host of experts in the fields of medical devices, nanotechnologies, user-centred design, regenerative medicine and trauma rehabilitation to explore promising concepts and their development in medical technologies for trauma surgery, with a particular focus on the role of nascent vibration technology in improving oncological and antibacterial therapies. The overarching goal is to explore trauma rehabilitation concepts and their development based on state-of-the-art patient-centred technology design, and to improve patient outcomes through the design of optimal technology that assists both patients and surgeons. Regenerative rehabilitation, where trauma patients are treated by methods of regenerative medicine, is an emerging field.

This conference will focus on discussing the following overarching themes related to novel vibration technologies in trauma rehabilitation to increase the malignant cell destruction capability in oncological therapies and reduce bacteria that could cause post-surgical complications due to infection:

  • Biomaterials and biomechanics: Improving the strength, endurance and efficacy of biomaterials for therapeutic applications
  • Cell biology and biocompatibility: Enhancing therapies and patient outcomes by novel cell vibration techniques
  • Patient-centred technology design: Putting patients at the centre of therapeutic solutions in an interconnected healthcare setting
  • Organisational innovation: Innovating performance of hospitals and research institutes by considering all stakeholders and contexts of use.

As illustrated in the below image, the conference organisers and participants are collaborating with the DFG German Research Foundation to discuss the potential of developing a vibration bioreactor under the premise that cells react to vibration and can reduce harmful bacteria.

Ameliot has been delighted to contribute to this 2nd international conference because the design of healthcare and medical technologies and experiences that puts the patients and clinicians at the heart of them lies at the core of what we do.